Clinical trials: Hypoactive Delirium
Hypoactive Delirium
Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure
Delirium within the intensive care unit (ICU) is associated with poor outcomes such as increased mortality, ICU and hospital length of stay (LOS), and time on mechanical ventilation.
- Trial name
- FLYP (NCT02899156)
- Testing
- Flumazenil
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- University of California, Davis